Literature DB >> 26712002

GR SUMOylation and formation of an SUMO-SMRT/NCoR1-HDAC3 repressing complex is mandatory for GC-induced IR nGRE-mediated transrepression.

Guoqiang Hua1, Laetitia Paulen1, Pierre Chambon2.   

Abstract

Unique among the nuclear receptor superfamily, the glucocorticoid (GC) receptor (GR) can exert three distinct transcriptional regulatory functions on binding of a single natural (cortisol in human and corticosterone in mice) and synthetic [e.g., dexamethasone (Dex)] hormone. The molecular mechanisms underlying GC-induced positive GC response element [(+)GRE]-mediated activation of transcription are partially understood. In contrast, these mechanisms remain elusive for GC-induced evolutionary conserved inverted repeated negative GC response element (IR nGRE)-mediated direct transrepression and for tethered indirect transrepression that is mediated by DNA-bound NF-κB/activator protein 1 (AP1)/STAT3 activators and instrumental in GC-induced anti-inflammatory activity. We demonstrate here that SUMOylation of lysine K293 (mouse K310) located within an evolutionary conserved sequence in the human GR N-terminal domain allows the formation of a GR-small ubiquitin-related modifiers (SUMOs)-NCoR1/SMRT-HDAC3 repressing complex mandatory for GC-induced IR nGRE-mediated direct repression in vitro, but does not affect transactivation. Importantly, these results were validated in vivo: in K310R mutant mice and in mice ablated selectively for nuclear receptor corepressor 1 (NCoR1)/silencing mediator for retinoid or thyroid-hormone receptors (SMRT) corepressors in skin keratinocytes, Dex-induced direct repression and the formation of repressing complexes on IR nGREs were impaired, whereas transactivation was unaffected. In mice selectively ablated for histone deacetylase 3 (HDAC3) in skin keratinocytes, GC-induced direct repression, but not bindings of GR and of corepressors NCoR1/SMRT, was abolished, indicating that HDAC3 is instrumental in IR nGRE-mediated repression. Moreover, we demonstrate that the binding of HDAC3 to IR nGREs in vivo is mediated through interaction with SMRT/NCoR1. We also show that the GR ligand binding domain (LBD) is not required for SMRT-mediated repression, which can be mediated by a LBD-truncated GR, whereas it is mandatory for NCoR1-mediated repression through an interaction with K579 in the LBD.

Entities:  

Keywords:  GC-induced direct transrepression; IR nGRE; SUMOylation; glucocorticoid receptor

Mesh:

Substances:

Year:  2015        PMID: 26712002      PMCID: PMC4747746          DOI: 10.1073/pnas.1522821113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Distinct classes of transcriptional activating domains function by different mechanisms.

Authors:  D Tasset; L Tora; C Fromental; E Scheer; P Chambon
Journal:  Cell       Date:  1990-09-21       Impact factor: 41.582

2.  Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA.

Authors:  B F Luisi; W X Xu; Z Otwinowski; L P Freedman; K R Yamamoto; P B Sigler
Journal:  Nature       Date:  1991-08-08       Impact factor: 49.962

Review 3.  Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases.

Authors:  Eleonore Beurel; Steven F Grieco; Richard S Jope
Journal:  Pharmacol Ther       Date:  2014-11-27       Impact factor: 12.310

4.  Three amino acids of the oestrogen receptor are essential to its ability to distinguish an oestrogen from a glucocorticoid-responsive element.

Authors:  S Mader; V Kumar; H de Verneuil; P Chambon
Journal:  Nature       Date:  1989-03-16       Impact factor: 49.962

5.  Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases.

Authors:  A K Indra; X Warot; J Brocard; J M Bornert; J H Xiao; P Chambon; D Metzger
Journal:  Nucleic Acids Res       Date:  1999-11-15       Impact factor: 16.971

6.  SUMO-mediated inhibition of glucocorticoid receptor synergistic activity depends on stable assembly at the promoter but not on DAXX.

Authors:  Sam R Holmstrom; Sergey Chupreta; Alex Yick-Lun So; Jorge A Iñiguez-Lluhí
Journal:  Mol Endocrinol       Date:  2008-06-18

7.  Jalview Version 2--a multiple sequence alignment editor and analysis workbench.

Authors:  Andrew M Waterhouse; James B Procter; David M A Martin; Michèle Clamp; Geoffrey J Barton
Journal:  Bioinformatics       Date:  2009-01-16       Impact factor: 6.937

8.  Molecular switch in the glucocorticoid receptor: active and passive antagonist conformations.

Authors:  Guillaume A Schoch; Brigitte D'Arcy; Martine Stihle; Dominique Burger; Dominik Bär; Jörg Benz; Ralf Thoma; Armin Ruf
Journal:  J Mol Biol       Date:  2009-11-11       Impact factor: 5.469

Review 9.  Maps and legends: the quest for dissociated ligands of the glucocorticoid receptor.

Authors:  Andrew R Clark; Maria G Belvisi
Journal:  Pharmacol Ther       Date:  2011-12-23       Impact factor: 12.310

10.  SUMOylation regulates the chromatin occupancy and anti-proliferative gene programs of glucocorticoid receptor.

Authors:  Ville Paakinaho; Sanna Kaikkonen; Harri Makkonen; Vladimir Benes; Jorma J Palvimo
Journal:  Nucleic Acids Res       Date:  2013-11-04       Impact factor: 16.971

View more
  39 in total

1.  A trilogy of glucocorticoid receptor actions.

Authors:  Chek Kun Tan; Walter Wahli
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-20       Impact factor: 11.205

2.  The glucocorticoid receptor agonistic modulators CpdX and CpdX-D3 do not generate the debilitating effects of synthetic glucocorticoids.

Authors:  Guoqiang Hua; Naimah Zein; Laetitia Paulen; Pierre Chambon
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-20       Impact factor: 11.205

3.  Glucocorticoid receptor modulators CpdX and CpdX-D3 exhibit the same in vivo antiinflammatory activities as synthetic glucocorticoids.

Authors:  Guoqiang Hua; Naimah Zein; François Daubeuf; Pierre Chambon
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-21       Impact factor: 11.205

4.  Agonist-specific Protein Interactomes of Glucocorticoid and Androgen Receptor as Revealed by Proximity Mapping.

Authors:  Joanna K Lempiäinen; Einari A Niskanen; Kaisa-Mari Vuoti; Riikka E Lampinen; Helka Göös; Markku Varjosalo; Jorma J Palvimo
Journal:  Mol Cell Proteomics       Date:  2017-06-13       Impact factor: 5.911

Review 5.  The Roles of SUMO in Metabolic Regulation.

Authors:  Elena Kamynina; Patrick J Stover
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 6.  Genomic effects of glucocorticoids.

Authors:  Ivana Grbesa; Ofir Hakim
Journal:  Protoplasma       Date:  2016-12-24       Impact factor: 3.356

Review 7.  Glucocorticoid and cytokine crosstalk: Feedback, feedforward, and co-regulatory interactions determine repression or resistance.

Authors:  Robert Newton; Suharsh Shah; Mohammed O Altonsy; Antony N Gerber
Journal:  J Biol Chem       Date:  2017-03-10       Impact factor: 5.157

Review 8.  A gradient of glucocorticoid sensitivity among helper T cell cytokines.

Authors:  Jesus Banuelos; Nicholas Z Lu
Journal:  Cytokine Growth Factor Rev       Date:  2016-05-13       Impact factor: 7.638

Review 9.  Therapeutic glucocorticoids: mechanisms of actions in rheumatic diseases.

Authors:  Rowan S Hardy; Karim Raza; Mark S Cooper
Journal:  Nat Rev Rheumatol       Date:  2020-02-07       Impact factor: 20.543

10.  The glucocorticoid receptor in osteoprogenitors regulates bone mass and marrow fat.

Authors:  Jessica L Pierce; Ke-Hong Ding; Jianrui Xu; Anuj K Sharma; Kanglun Yu; Natalia Del Mazo Arbona; Zuleika Rodriguez-Santos; Paul Bernard; Wendy B Bollag; Maribeth H Johnson; Mark W Hamrick; Dana L Begun; Xing M Shi; Carlos M Isales; Meghan E McGee-Lawrence
Journal:  J Endocrinol       Date:  2019-07-01       Impact factor: 4.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.